Author:
Zachariah Ongwae H.,Lizzy Mwamburi A.,Rose Kakai,Angela Mutuku M.
Abstract
Abstract
Background
Diarrhoea is a common cause of mortality and morbidity in children under five years old. In Kenya, it has a 21% case fatality with Enteropathogenic E. coli, Campylobacter jejuni, Shigella spp. and Salmonella spp. accounting for 50–60% of the cases. Sulphonamides, tetracycline, ampicillin and trimethoprim/sulfamethoxazole are typically used in the treatment of diarrhoeal diseases but have become ineffective in the face of emerging antimicrobial resistance. The objective of this study was to evaluate the prevalence and antimicrobial susceptibility of Campylobacter jejuni and Shigella species in children under five years of age presenting with diarrhoea at Kapsabet County Referral Hospital in Kenya.
Methods
Faecal samples were collected from 139 children admitted with diarrhoea. Each sample was examined macroscopically for colour, texture, and presence of extraneous material. The samples were then cultured for bacterial growth. Observed bacterial growth was isolated and identified by a series of biochemical tests. Resistance patterns were also evaluated using the Kirby – Bauer Disk diffusion method. The chi – square test and Pearson Correlation Coefficient were used to establish statistical significance.
Results
Approximately 33.1% of the total faecal samples tested were positive for enteric pathogens. Shigella spp. demonstrated resistance to erythromycin (91.7%), doxycyclin (83.3%), ampicillin (82.1%), cotrimoxazole (73.1%), minocycline (66.7%) and cefuroxime (54.2%). Campylobacter jejuni also exhibited resistance to erythromycin (87.5%), doxycyclin (75%), ampicillin (73.7%), cotrimoxazole (73.3%) and minocycline (68.8%).
Conclusions
The resistance patterns of Shigella spp. and Campylobacter jejuni reported in this study necessitates the need for a comprehensive multiregional investigation to evaluate the geographical prevalence and antimicrobial resistance distributions of these microorganisms. These findings also support the need for the discovery and development of effective therapeutic alternatives.
Trial registration
Retrospectively registered. Certificate No. 00762
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. World Health Organization. Antimicrobial resistance: global report on surveillance. World Health Organization; 2014.
2. Brooks JT, Shapiro RL, Kumar L, Wells JG, Phillips-Howard PA, Shi YP, Vulule JM, Hoekstra RM, Mintz E, Slutsker L. Epidemiology of sporadic bloody diarrhoea in rural Western Kenya. Am J Tropical Med Hygiene. 2003;68(6):671–7.
3. O'Reilly CE, Jaron P, Ochieng B, Nyaguara A, Tate JE, et al. Risk factors for death among children less than 5 years old hospitalized with Diarrhea in rural Western Kenya, 2005–2007: a cohort study. PLoS Med. 2012;9(7):e1001256. https://doi.org/10.1371/journal.pmed.1001256.
4. Stef L, Cean A, Vasile A, Julean C, Drinceanu D, Corcionivoschi N. Virulence characteristics of five new campylobacter jejuni chicken isolates. Gut Pathogens. 2013;5(1):1–7.
5. Okeke IN, Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA. Growing Problem of Multidrug-Resistant Enteric Pathogens in Africa. Perspective, Volume 13, Number 11 CDC; 2007.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献